Sulfonimidamides in Medicinal and Agricultural Chemistry

被引:163
作者
Chinthakindi, Praveen K. [1 ]
Naicker, Tricia [1 ]
Thota, Niranjan [1 ]
Govender, Thavendran [1 ]
Kruger, Hendrik G. [1 ]
Arvidsson, Per I. [1 ,2 ,3 ]
机构
[1] Univ KwaZulu Natal, Catalysis & Peptide Res Unit, ZA-4001 Durban, South Africa
[2] Karolinska Inst, Dept Med Biochem & Biophys, Sci Life Lab, Drug Discovery & Dev Platform, S-17177 Stockholm, Sweden
[3] Karolinska Inst, Dept Med Biochem & Biophys, Div Translat Med & Chem Biol, S-17177 Stockholm, Sweden
基金
新加坡国家研究基金会;
关键词
agricultural chemistry; bioisosteres; drug design; medicinal chemistry; sulfonimidamides; NITROXYL HNO; DRUG DISCOVERY; IN-VITRO; SULFOXIMINES; ACID; BIOISOSTERES; SULFONAMIDES; INHIBITORS; DESIGN; ANALOG;
D O I
10.1002/anie.201610456
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The synthesis and evaluation of structural analogues and isosteres are of central importance in medicinal and agricultural chemistry. The sulfonamide functional group represents one of the most important amide isosteres in contemporary drug design, and about 500 such compounds have overcome both the pharmacological and regulatory hurdles that precede studies in humans. The mono aza analogues of sulfonamides, that is, sulfonimidamides, are rapidly gaining popularity as a novel functional group among synthetic chemists involved in the design of biologically active compounds for both pharmaceutical and agrochemical applications. Herein, we review these recent developments to showcase the promise of this functional group.
引用
收藏
页码:4100 / 4109
页数:10
相关论文
共 66 条
  • [21] Gnamm C., 2015, WO 2015/124563, Patent No. 2015124563
  • [22] Novel diamide insecticides: Sulfoximines, sulfonimidamides and other new sulfonimidoyl derivatives
    Gnamm, Christian
    Jeanguenat, Andre
    Dutton, Ana C.
    Grimm, Christoph
    Kloer, Daniel P.
    Crossthwaite, Andrew J.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (11) : 3800 - 3806
  • [23] Guba W., 2015, [No title captured], Patent No. [2015091595, WO2015091595A1]
  • [24] Hansen P., 2005, [No title captured], Patent No. [WO2005026124A1, 2005026124, WO2005026124]
  • [25] Hillemann C. L., 1986, [No title captured], Patent No. [EP 173498 A1, 173498]
  • [26] Hillemann C. L., 1986, [No title captured], Patent No. [US 4705555, 4705555]
  • [27] The role of ligand efficiency metrics in drug discovery
    Hopkins, Andrew L.
    Keserue, Gyoergy M.
    Leeson, Paul D.
    Rees, David C.
    Reynolds, Charles H.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (02) : 105 - 121
  • [28] HOWBERT J J, 1991, Drugs of the Future, V16, P517
  • [29] NOVEL AGENTS EFFECTIVE AGAINST SOLID TUMORS - THE DIARYLSULFONYLUREAS - SYNTHESIS, ACTIVITIES, AND ANALYSIS OF QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS
    HOWBERT, JJ
    GROSSMAN, CS
    CROWELL, TA
    RIEDER, BJ
    HARPER, RW
    KRAMER, KE
    TAO, EV
    AIKINS, J
    POORE, GA
    RINZEL, SM
    GRINDEY, GB
    SHAW, WN
    TODD, GC
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (09) : 2393 - 2407
  • [30] Nitroxyl (HNO): the Cinderella of the nitric oxide story
    Irvine, Jennifer C.
    Ritchie, Rebecca H.
    Favaloro, Joanne L.
    Andrews, Karen L.
    Widdop, Robert E.
    Kemp-Harper, Barbara K.
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2008, 29 (12) : 601 - 608